Viking Therapeutics, Inc.
Industry: Life Sciences ・ $VKTX on Nasdaq
Insider Sale
+$8,363,070
-7.59%
Shares
Shares Volume: 194,490 Shares
Average Share Price: $43
INSIDER
Lian Brian
President & CEO (Director)
reported on Jan 6 2025
traded on Jan 3 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
NEW SHARES OWNERSHIP AMOUNT | 2,366,570 |
PURCHASES/SALES 1Y | 0 / 9 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $5,505,553.97 |
INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
PURCHASES/SALES 1Y | 0 / 25 |
P/S VALUE RATIO | N/A |
AVERAGE SALE VALUE | $4,014,968.97 |
COMPANY PREVIOUS TRADES |